文献速递心力衰竭与心肌病

基于体重变化的利尿剂干预对慢性心衰患者心功能及再入院率的影响

[The impact of weight management and related diuretic medication intervention based on body weight changes on cardiac function and re-hospitalization rate in patients with chronic congestive heart failure].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2017-01-01

该前瞻性随机对照研究纳入350例慢性充血性心力衰竭患者,干预组接受体重管理指导并根据体重变化调整出院后利尿剂方案,对照组接受常规医疗照护。6个月后干预组LVEF和6分钟步行距离显著优于对照组,NT-proBNP显著低于对照组,再住院率11.83%显著低于对照组33.14%。

要点

  • 基于体重变化调整利尿剂可显著改善CHF患者6个月LVEF和6分钟步行距离。
  • 干预组6个月再住院率11.83%,显著低于对照组的33.14%。
  • 干预组NT-proBNP在6个月时显著低于对照组。

核心结论

  • 以体重为指导的管理和利尿剂方案调整干预可改善CHF患者心功能并降低再住院率。

研究设计与样本

  • 前瞻性随机对照研究,连续入选2014年6月至2016年6月住院的CHF患者350例,随机分为干预组175例和对照组175例。
  • 干预组接受体重管理指导并根据体重变化调整出院后利尿剂方案,对照组接受常规医疗照护。
  • 主要观察指标为LVEF、NT-proBNP、6分钟步行距离和NYHA心功能分级,于出院前1天和出院6个月时检测。

主要发现

  • 出院前1天两组LVEF、NT-proBNP和6分钟步行距离差异均无统计学意义(P均>0.05)。
  • 出院6个月时干预组LVEF和6分钟步行距离均优于对照组(P均<0.01),NT-proBNP低于对照组(P<0.01)。
  • 干预组出院6个月时LVEF和6分钟步行距离较出院前1天明显改善(P均<0.01),NT-proBNP亦明显降低(P<0.01)。
  • 对照组出院6个月时LVEF较出院前1天改善(P=0.035),但NT-proBNP和6分钟步行距离无明显变化(P分别为0.328和0.807)。
  • 干预组再住院率11.83%(20/169)明显低于对照组33.14%(56/169,χ²=21.99,P<0.01)。

关键数值与推荐

  • 干预组再住院率11.83%(20/169),对照组33.14%(56/169),χ²=21.99,P<0.01。
  • 出院6个月时干预组NYHA心功能分级改善优于对照组(Z=9.235,P<0.01)。

临床怎么用

  • 对CHF出院患者可开展体重管理指导,并根据体重变化调整利尿剂方案以改善心功能并降低再住院率。

局限性

  • 对照组退出4例、失访2例,干预组退出5例、失访1例,最终每组169例完成试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the impact of weight management and related medication intervention based on body weight changes on cardiac function among patients with chronic congestive heart failure (CHF). Methods: Using prospective, randomized, controlled study methods, consecutive CHF patients, who hospitalized in our department from June 2014 to June 2016 (n=350), were randomly divided into intervention group (n=175) and control group (n=175). Patients in the intervention group received weight management guidance and the post discharge diuretic drugs regimen was adjusted based on body weight changes. The control group received routine medical care post discharge. Left ventricular ejection fraction (LVEF), B type natriuretic peptide precursor (NT-proBNP), 6 minutes walk distance and NYHA classification at one day before discharge and after 6 months were compared between the two groups respectively. Results: Follow-up visit data were not available from 6 patients in the control and intervention group respectively. NYHA classification, LVEF, NT-proBNP and 6 minutes walk distance were similar between the two groups at one day before discharge (all P>0.05). After 6 months, the LVEF and 6 minutes walk distance were significantly higher while NT-proBNP level was significantly lower in the intervention group compared to the control group (all P<0.01). Meanwhile, the LVEF and 6 minutes walk distance were significantly increased, while NT-proBNP was significantly reduced at 6 months post discharge compared to one day before discharge in the intervention group (all P<0.01). The LVEF was also significantly improved (P=0.035), but the NT-proBNP and 6 minutes walk distance were similar (P were 0.328 and 0.807 respectively) at 6 months after discharge compared to one day before discharge in the control group. The NYHA classification was significantly lower in intervention group and in control group at 6 months after discharge compared to one day before discharge (Z=5.154, P<0.01 and Z=10.497, P<0.01), and the NYHA classification improved more in the intervention group than in control group at 6 months after discharge (Z=9.235, P<0.01). The re-hospitalization rate of CHF patients in intervention group was 11.83% (20/169), which was significantly lower than the control group (33.14% (56/169), χ(2)=21.99, P<0.01). At 6 months follow up, body weight remained unchanged in the intervention group, while body weight tended to be higher in the control group compared to one day before discharge. Conclusion: The weight management and diuretic drug regimen adjudgment intervention based on body weight changes can improve cardiac function and reduced re-hospitalization rate in CHF patients. 目的: 探讨以体重为指导的管理和干预对慢性心力衰竭(CHF)患者心功能的影响。 方法: 采用前瞻性随机对照研究方法,连续入选2014年6月至2016年6月在浦东新区光明中医医院住院治疗的CHF患者350例,采用随机数字表法分为干预组(175例)和对照组(175例)。干预组给予体重管理指导及干预,根据体重变化指导患者使用利尿剂。对照组出院时由心内科护士给予常规健康宣教。观察的主要指标包括左心室射血分数(LVEF)、血浆N末端B型利钠肽原(NT-proBNP)、6 min步行距离、纽约心脏协会(NYHA)心功能分级,分别于出院前1 d和出院6个月时检测患者上述指标。 结果: 随访期间,对照组患者退出4例、失访2例,最终有169例患者完成试验,干预组患者退出5例、失访1例,最终有169例患者完成试验。出院前1 d,对照组和干预组患者LVEF、血浆NT-proBNP和6 min步行距离差异均无统计学意义(P均>0.05)。出院6个月时,干预组患者LVEF和6 min步行距离均优于对照组(P均<0.01),血浆NT-proBNP低于对照组(P<0.01)。出院6个月时,干预组患者LVEF和6 min步行距离均较出院前1 d明显改善(P均<0.01),血浆NT-proBNP亦较出院前1 d明显降低(P<0.01);对照组患者LVEF亦较出院前1 d明显改善(P=0.035),而血浆NT-proBNP和6 min步行距离无明显变化(P分别为0.328和0.807)。对照组和干预组患者出院6个月时NYHA心功能分级均有明显改善(分别为Z=5.154、P<0.01和Z=10.497、P<0.01),且干预组优于对照组(Z=9.235,P<0.01)。干预组患者心力衰竭再住院率为11.83%(20/169)明显低于对照组的33.14%(56/169,χ(2)=21.99,P<0.01)。 结论: 以体重为指导的管理和干预可以改善CHF患者心功能。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang FW, Shi J, Shi J, et al. [The impact of weight management and related diuretic medication intervention based on body weight changes on cardiac function and re-hospitalization rate in patients with chronic congestive heart failure]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 29081178. doi:10.3760/cma.j.issn.0253-3758.2017.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。